MVP
FLXN

Miller Value Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Miller Value Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,101,735
Closed -$36.7M – 130
2021
Q1 		$36.7M Sell
4,101,735
-94,365
-2% -$1.08M 0.95% 41
2020
Q4 		$48.4M Sell
4,196,100
-1,078,339
-20% -$12.5M 1.47% 33
2020
Q3 		$54.9M Buy
5,274,439
+78,889
+2% +$967K 1.97% 18
2020
Q2 		$68.3M Buy
5,195,550
+956,081
+23% +$9.91M 3.03% 8
2020
Q1 		$33.4M Sell
4,239,469
-693,406
-14% -$10.4M 2.15% 23
2019
Q4 		$102M Sell
4,932,875
-282,935
-5% -$4.77M 3.62% 5
2019
Q3 		$71.5M Buy
5,215,810
+363,350
+7% +$4.31M 2.87% 11
2019
Q2 		$59.7M Buy
4,852,460
+742,740
+18% +$8.57M 2.27% 22
2019
Q1 		$51.3M Buy
4,109,720
+996,330
+32% +$13.3M 2.03% 25
2018
Q4 		$35.2M Buy
3,113,390
+232,190
+8% +$3.64M 1.6% 29
2018
Q3 		$53.9M Buy
2,881,200
+227,425
+9% +$5.23M 1.74% 28
2018
Q2 		$68.6M Sell
2,653,775
-16,125
-0.6% -$418K 2.56% 12
2018
Q1 		$59.8M Sell
2,669,900
-14,600
-0.5% -$356K 2.49% 16
2017
Q4 		$67.2M Buy
2,684,500
+1,503,175
+127% +$36.8M 2.86% 13
2017
Q3 		$28.6M Buy
1,181,325
+653,525
+124% +$15.4M 1.23% 29
2017
Q2 		$10.7M Buy
+527,800
New +$11M 0.43% 36

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Miller Value Partners's FLXN Position: Q2 2021 in Review

Miller Value Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2021, closing a stake of 4,101,735 shares — an estimated $36.7M sold.

Miller Value Partners first reported a position in FLXN in Q2 2017 and held it in 16 quarters. The position peaked at $102M in Q4 2019. 140 funds tracked by Wall St. Rank hold FLXN as of Q2 2021.

  • Miller Value Partners reported no remaining Flexion Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Miller Value Partners sold 4,101,735 Flexion Therapeutics, Inc. shares in Q2 2021, an estimated $36.7M.
  • Miller Value Partners first reported a position in Flexion Therapeutics, Inc. in Q2 2017 and held it in 16 quarters.
  • Miller Value Partners's Flexion Therapeutics, Inc. position peaked at $102M in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2021.

Based on Miller Value Partners's 13F filing for Q2 2021, filed 16 Aug 2021.